Amortization expense was approximately $42 and $46 for the three months ended September 30, 2019 and 2018, respectively, and approximately $121 and $139 for the nine months ended September 30, 2019 and 2018, respectively.
During the third quarter of 2017, we revised the June 2016 Plan.
This acquisition provides us with a new core temperature sensing technology that expands our sensing product portfolio, while increasing our presence in the industrial and medical markets.
Our effective income tax rate was 62.2% and 28.9% in the third quarters of 2019 and 2018, respectively.
Generally, these RSUs vest over a three-year period.
QTI, doing business as QTI Sensing Solutions, is a leading designer and manufacturer of high-quality temperature sensors serving original equipment manufacturers with mission-critical applications in the industrial, aerospace, defense and medical markets.
Goodwill represents value the Company expects to be created by combining the operations of the acquired business with the Company's operations, including the expansion of customer relationships within our existing business, access to new customers, and potential cost savings and synergies.
Our effective income tax rate was 30.3% and 29.7% for the nine months ended September 30, 2019 and 2018, respectively.
In June 2016, we announced plans to restructure operations by phasing out production at our Elkhart facility and transitioning it into a research and development center supporting our global operations ("June 2016 Plan").
Transaction losses for the three months and nine months ended September 30, 2019 were $2,473 and $2,828, respectively and transaction losses for the three and nine months ended September 30, 2018 were $1,740 and $2,658, respectively, which have been included in other income (expense) in the Condensed Consolidated Statement of Earnings.
This increase is primarily attributed to the net impact of changes in reserves relating to uncertain tax positions.Gross margin as a percent of sales was 32.0% in the third quarter of 2019 compared to 35.4% in the third quarter of 2018.
Research and development expenses were $6,806 or 5.9% of sales in the third quarter of 2019 compared to $6,517 or 5.5% of sales in the comparable quarter of 2018.
Sales were $115,651 in the third quarter of 2019, a decrease of $3,208 or 2.7% from the third quarter of 2018.
Operating earnings were $10,124 or 8.8% of sales in the third quarter of 2019 compared to operating earnings of $16,118 or 13.6% of sales in the third quarter of 2018.
Research and development expenses were $19,854 or 5.6% of sales in the nine months ended September 30, 2019 compared to $19,500 or 5.6% of sales in the nine months ended September 30, 2018.
Restructuring charges were $997 or 0.8% of sales in the third quarter of 2018.
Restructuring charges were $2,342 or 2.0% of sales in the third quarter of 2019.